HMG-CoA Reductase Inhibitors (Statins) Increase Endothelial Progenitor Cells via the PI 3-Kinase/Akt Pathway

Journal of Clinical Investigation - United States
doi 10.1172/jci13152
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

HMG CoA Reductase Inhibitors (Statins) for Dialysis Patients

2009English

Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

HMG CoA Reductase Inhibitors (Statins) for People With Chronic Kidney Disease Not Requiring Dialysis

Cochrane Database of Systematic Reviews
2014English

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine
Medicine
2011English

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers

ISRN Dentistry
2011English

Oxidized Low-Density Lipoprotein Induces Apoptosis in Endothelial Progenitor Cells by Inactivating the Phosphoinositide 3-Kinase/Akt Pathway

Journal of Vascular Research
Cardiovascular MedicinePhysiologyCardiology
2010English

HMG-CoA Reductase Inhibitors (Statins) Might Cause High Elevations of Creatine Phosphokinase (CK) in Patients With Unnoticed Hypothyroidism

Endocrine Journal
EndocrinologyMetabolismDiabetes
2006English

Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Novel Synthetic Inhibitors of 3-Hydroxy-3-Methylglutaryl-Coenzyme a (HMG-CoA) Reductase Activity That Inhibit Tumor Cell Proliferation and Are Structurally Unrelated to Existing Statins

International Journal of Molecular Medicine
MedicineGenetics
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy